Are alarm symptoms predictive of cancer survival? Population-based cohort study

British Journal of General Practice

Volumn 63, Issue 617, 2013, Pages

  Dregan, Alex ^a,b   Møller, Henrik ^a   Charlton, Judith ^a,b   Gulliford, Martin C ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Alarm symptom; Colorectal cancer; Gastro oesophageal cancer; General practice; Primary care; Survival

Indexed keywords

ADULT; ALARM SYMPTOM; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; COHORT ANALYSIS; COLORECTAL CANCER; CONSULTATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DYSPHAGIA; ESOPHAGUS CANCER; FEMALE; GENERAL PRACTICE; HEMATURIA; HEMOPTYSIS; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; RECTUM HEMORRHAGE; SURVIVAL PREDICTION; SURVIVAL RATE; SYMPTOM; SYMPTOM ASSESSMENT; URINARY TRACT CANCER; AGED; CLINICAL TRIAL; DEGLUTITION DISORDERS; DELAYED DIAGNOSIS; EARLY DIAGNOSIS; EVALUATION STUDY; GASTROINTESTINAL HEMORRHAGE; MORTALITY; MULTICENTER STUDY; NEOPLASMS; PATIENT ATTITUDE; PATIENT REFERRAL; RECTAL DISEASES; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TIME TO TREATMENT;

ADULT; AGED; COHORT STUDIES; DEGLUTITION DISORDERS; DELAYED DIAGNOSIS; EARLY DETECTION OF CANCER; FEMALE; GASTROINTESTINAL HEMORRHAGE; GENERAL PRACTICE; HEMATURIA; HEMOPTYSIS; HUMANS; MALE; NEOPLASMS; PATIENT ACCEPTANCE OF HEALTH CARE; RECTAL DISEASES; REFERRAL AND CONSULTATION; RISK FACTORS; TIME-TO-TREATMENT;

EID: 84888781572     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp13X675197     Document Type: Article

References (20)

1. Berrino F, De Angelis R, Sant M, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 2007; 8(9): 773-783.
2. Moller H, Sandin F, Bray F, et al. Breast cancer survival in England, Norway and Sweden: a population-based comparison. Int J Cancer 2010; 127(11): 2630-2638.
3. Hamilton W, Round A, Sharp D, Peters TJ. Clinical features of colorectal cancer before diagnosis: a population-based case-control study. Br J Cancer 2005; 93(4): 399-405.
4. Shephard EA, Stapley S, Neal RD, et al. Clinical features of bladder cancer in primary care. Br J Gen Pract 2012; DOI: 10.3399/bjgp12X654560.
5. Stapley S, Peters TJ, Sharp D, Hamilton W. The mortality of colorectal cancer in relation to the initial symptom at presentation to primary care and to the duration of symptoms: a cohort study using medical records. Br J Cancer 2006; 95(10): 1321-1325.
6. Stapley S, Peters TJ, Neal RD, et al. The risk of oesophago-gastric cancer in symptomatic patients in primary care: a large case-control study using electronic records. Br J Cancer 2013; 108(1): 25-31.
7. Astin M, Griffin T, Neal RD, et al. The diagnostic value of symptoms for colorectal cancer in primary care: a systematic review. Br J Gen Pract 2011; DOI: 10.3399/bjgp11X572427.
8. Hamilton W, Peters TJ, Round A, Sharp D. What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study. Thorax 2005; 60(12): 1059-1065.
9. Jones R, Latinovic R, Charlton J, Gulliford MC. Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research Database. BMJ 2007; 334(7602): 1040.
10. Lyratzopoulos G, Neal RD, Barbiere JM, et al. Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 National Cancer Patient Experience Survey in England. Lancet Oncol 2012; 13(4): 353-365.
11. Gulliford MC, Petruckevitch A, Burney PG. Survival with bladder cancer, evaluation of delay in treatment, type of surgeon, and modality of treatment. BMJ 1991; 303(6800): 437-440.
12. Tørring ML, Frydenberg M, Hansen RP, et al. Time to diagnosis and mortality in colorectal cancer: a cohort study in primary care. Br J Cancer 2011; 104(6): 934-940.
13. Dregan A, Moller H, Murray-Thomas T, Gulliford MC. Validity of cancer diagnosis in a primary care database compared with linked cancer registrations in England. Population-based cohort study. Cancer Epidemiol 2012; 36(5): 425-429.
14. Gulliford M. Primary care and diagnosis of cancer. Lancet Oncol 2012; 13(4): 321-323.
15. Terhaar sive Droste JS, Oort FA, van der Hulst RW, et al. Does delay in diagnosing colorectal cancer in symptomatic patients affect tumor stage and survival? A population-based observational study. BMC Cancer 2010; 10: 332.
16. Ramos M, Esteva M, Cabeza E, et al. Relationship of diagnostic and therapeutic delay with survival in colorectal cancer: a review. Eur J Cancer 2007; 43(17): 2467-2478.
17. Wallace DM, Bryan RT, Dunn JA, et al; West Midlands Urological Research G. Delay and survival in bladder cancer. BJU Int 2002; 89(9): 868-878.
18. Crawford SC, Davis JA, Siddiqui NA, et al. The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. BMJ 2002; 325(7357): 196.
19. Symonds P, Bolger B, Hole D, et al. Advanced-stage cervix cancer: rapid tumour growth rather than late diagnosis. Br J Cancer 2000; 83(5): 566-568.
20. Fox R, Fletcher J. Alarm symptoms in primary care. BMJ 2007; 334(7602): 1013-1014.